Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease-Reference-Cited by-同舟云学术

Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease

Published:2021-03-26 Issue:12 Volume:100 Page:e25122
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Conigliaro Paola,Chimenti Maria Sole,Triggianese Paola,D’Antonio Arianna,Sena Giorgia,Alfieri Norma,Biancone Livia,Perricone Roberto

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference8 articles.

1. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients;Conigliaro;Autoimmun Rev,2016

2. Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach;Chimenti;Clin Exp Rheumatol,2019

3. The efficacy and safety of golimumab as third- or fourth-line anti-TNF therapy in patients with refractory Crohn's disease: a case series;Russi;Inflamm Intest Dis,2017

4. Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study;Martineau;Aliment Pharmacol Ther,2017

5. Induction of inflammatory bowel disease flares by golimumab: report of three patients with enteropathic spondylarthritis or ankylosing spondylitis and comorbid colitis;Fiehn;Arthritis Rheum,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies;Nature Reviews Rheumatology;2023-06-29

2. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease;Journal of Crohn's and Colitis;2023-06-23

3. Inflammatory bowel disease: focus on enteropathic arthritis and therapy;Rheumatology and Immunology Research;2022-06-01

4. Reasons and Factors Contributing to Chinese Patients’ Preference for Ustekinumab in Crohn’s Disease: A Multicenter Cross-Sectional Study;Frontiers in Pharmacology;2021-11-22

5. Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement;Clinical Rheumatology;2021-08-19